Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04358757 · ClinicalTrials.gov registry record
Immune and Physical Recovery Following Cesarean Delivery
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 60
- Enrollment target
NCT04358757: Completed study, sponsored by Stanford University.
NCT04358757 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04358757 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
Pregnancy results in an altered immune state compared to the nonpregnant population. A significant proportion of women undergoing cesarean delivery recover poorly. The first step to determining whether this is an immune driven / associated process is to characterise what effects this surgery has on maternal immune function. "Normal" changes will be evaluated in maternal immune function and activity precipitated by surgery and delivery of the neonate. Immune response to surgery will be compared to historical immune data from patients undergoing non-obstetric surgery (orthopaedic patients).
Primary Outcome
immune changes include: leukocyte subset distribution, intracellular signaling pathway activity within leukocyte subsets and cytokine-induced responses to ex-vivo stimulation in leukocyte subsets
Interventions
- PROCEDURE Elective cesarean delivery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2019-11-22 |
| Est. Completion | 2023-12-23 |
What the finished NCT04358757 record still lists
NCT04358757 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Elective cesarean delivery is the first listed.
NCT04358757 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04358757 about?
NCT04358757 is a clinical study titled "Immune and Physical Recovery Following Cesarean Delivery". Pregnancy results in an altered immune state compared to the nonpregnant population. A significant proportion of women undergoing cesarean delivery recover poorly. The first step to determining whether this is an immune driven / associated process is to characterise what effects this surgery has on ...
What is the current status of trial NCT04358757?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2019-11-22. Estimated completion is 2023-12-23.
What interventions are being tested in trial NCT04358757?
The interventions under investigation include: Elective cesarean delivery (PROCEDURE).
Who is sponsoring clinical trial NCT04358757?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI